Insider Transactions in Q4 2024 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 15
2024
|
Regan J Lauer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,503
-6.5%
|
$15,006
$2.87 P/Share
|
Dec 15
2024
|
Regan J Lauer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,031
+15.42%
|
-
|
Dec 10
2024
|
Patrick Soon Shiong Director |
BUY
Conversion of derivative security
|
Indirect |
117,185,260
+18.0%
|
$234,370,520
$2.11 P/Share
|